H-Quotient Plans Expansion; Patent Filed for Software-Controlled Implantable Monitoring Cardiac Device
VIENNA, Va., Jun 17, 2004 (BUSINESS WIRE) -- H-Quotient, Inc., (HQNTE), announced that it is in advanced negotiations to expand its medical products division through a stake in a software-controlled implantable monitoring cardiac device designed to enhance pacemakers by helping to prevent sudden cardiac death. The product is designed to detect arrhythmia, a disorder in the heart rate that leads to myocardial infarction (heart attack) that claims 300,000 lives each year. A patent application has been filed by the inventor with the U.S. Patent Office. FDA protocol development is ongoing and is expected to be completed within two months.
I don't bash. I just post the truth and they call it bashing.